Literature DB >> 19955903

An acute hepatitis resembling autoimmune hepatitis occurring during imatinib therapy in a gastrointestinal stromal tumor patient.

Sandra Aliberti1, Giovanni Grignani, Paolo Allione, Marco Fizzotti, Giovanni Galatola, Alberto Pisacane, Massimo Aglietta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19955903     DOI： 10.1097/COC.0b013e31802b4ef7

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN： 0277-3732            Impact factor:   2.339


× No keyword cloud information.
  8 in total

1.  Autoimmune-like hepatitis during masitinib therapy in an amyotrophic lateral sclerosis patient.

Authors:  Maria Salvado; Victor Vargas; Marta Vidal; Macarena Simon-Talero; Jessica Camacho; Josep Gamez
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

Review 2.  Drug-induced autoimmune hepatitis: A minireview.

Authors:  Chin Kimg Tan; Danielle Ho; Lai Mun Wang; Rahul Kumar
Journal:  World J Gastroenterol       Date:  2022-06-28       Impact factor: 5.374

Review 3.  Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.

Authors:  Jonathan G Stine; James H Lewis
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-12-25       Impact factor: 3.869

Review 4.  Drug-induced autoimmune-like hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-02-16       Impact factor: 3.487

5.  Imatinib-induced hyperbilirubinemia with UGT1A1 (*28) promoter polymorphism: first case series in patients with gastrointestinal stromal tumor.

Authors:  Muhammad Wasif Saif; Melissa Hennessey Smith; Antonia Maloney; Robert B Diasio
Journal:  Ann Gastroenterol       Date:  2016-06-10

6.  Immunosuppressant therapy successfully improved regorafenib-induced severe hepatic injury in a patient with metastatic gastrointestinal stromal tumor: A case report.

Authors:  Miyuki Kuwayama; Keita Uchino; Kotoe Takayoshi; Masato Komoda; Motoyuki Kohjima; Makoto Nakamuta; Seiya Momosaki; Hitoshi Kusaba; Koichi Akashi; Eishi Baba
Journal:  Oncol Lett       Date:  2015-11-02       Impact factor: 2.967

7.  Imatinib-induced Hepatitis in a Patient Treated for Gastrointestinal Stromal Tumor: A Rare Adverse Effect.

Authors:  Jamil M Shah; Kyawzaw Lin; Denzil Etienne; Madhavi Reddy; Yingxian Liu
Journal:  Cureus       Date:  2018-04-24

8.  Imaging of the chemotherapy-induced hepatic damage: Yellow liver, blue liver, and pseudocirrhosis.

Authors:  Linda Calistri; Vieri Rastrelli; Cosimo Nardi; Davide Maraghelli; Sofia Vidali; Michele Pietragalla; Stefano Colagrande
Journal:  World J Gastroenterol       Date:  2021-12-14       Impact factor: 5.742
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.